Rapport Therapeutics Inc.... (RAPP)
undefined
undefined%
At close: undefined
15.10
-19.85%
Pre-market Dec 16, 2024, 04:06 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22
Net Income -34.79M -10.65M
Depreciation & Amortization 112.00K 15.00K
Stock-Based Compensation 3.52M -
Other Working Capital 1.80M 1.49M
Other Non-Cash Items 1.32M 5.94M
Deferred Income Tax - -
Change in Working Capital 2.65M 1.49M
Operating Cash Flow -27.18M -3.24M
Capital Expenditures -1.64M -284.00K
Acquisitions - -
Purchase of Investments -77.22M -
Sales Maturities Of Investments - -
Other Investing Acitivies - -5.00M
Investing Cash Flow -78.86M -5.28M
Debt Repayment - 7.90M
Common Stock Repurchased -4.00K -
Dividend Paid - -
Other Financial Acitivies 145.09M -
Financial Cash Flow 145.14M 39.69M
Net Cash Flow 39.09M 31.16M
Free Cash Flow -28.82M -3.53M